A large subset of gliomas are now defined based on the presence/absence of isocitrate dehydrogenase (IDH) mutation, O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and 1p/19q co-deletion, which can help in management and stratification of glioma patients (5). Here, IDH3A is linked to glioma.